To confirm the association between IFI30 expression and the immune phenotype, immunohistochemical staining of CD163, PD‐L2, and IL‐10 was carried out on the glioma samples with low and high IFI30 expression levels.22, 23. This evidence concerns the gene IFI30 and central nervous system cancer.